Clinical Trials on Age, Parental

Total 2957 results

Kubota Vision Inc.

Completed

Study Evaluating Retinal Health Monitoring System Visual Acuity Module.

Age Related Macular Degeneration

United States
Centre Hospitalier Intercommunal Creteil

Completed

Patient's Feelings After Receiving a Diagnosis of Age-related Macular Degeneration (PANDA)

Age Related Macular Degeneration

France
Shahid Beheshti University of Medical Sciences

Unknown

Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial

Age Related Macular Degeneration

Iran, Islamic Republic of
University Hospital of Ferrara
Regione Emilia-Romagna

Completed

Single or Combined Protocols for NV-AMD

Age-Related Macular Degeneration
Brugmann University Hospital

Completed

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Age-Related Macular Degeneration

Belgium
Lawson Health Research Institute
The Physicians' Services Incorporated Foundation; Academic Health Science Centres

Completed

Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes

Age Related Macular Degeneration

Canada
Ulucanlar Eye Training and Research Hospital

Completed

Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration

Age Related Macular Degeneration
Astellas Institute for Regenerative Medicine

Withdrawn

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD (PORTRAY)

Age-Related Macular Degeneration

United States
Oxford BioMedica

Completed

Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD) (GEM)

Age Related Macular Degeneration

United States
University Hospital Hradec Kralove

Unknown

Treatment of AMD With Rheohemapheresis /RHF/ (TARHF)

Age Related Macular Degeneration

Czech Republic
Catholic University of the Sacred Heart

Unknown

Effect of Saffron Supplementation on Macular Cone-mediated Function in Age-related Macular Degeneration (safAMD)

Age-Related Macular Degeneration

Italy
Notal Vision Ltd.

Completed

Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

HMP (Home Macular Perimeter) -Usability Trial

Age Related Macular Degeneration
Forsight Vision4

Completed

Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

Latvia
Medical University of Vienna

Terminated

Macular Pigment Optical Density in Healthy Subjects

Age Related Macular Degeneration

Austria
Johns Hopkins University
Alimera Sciences; pSiVida Limited

Completed

The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot (MAP)

Age Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

Usage of the Home Macular Perimeter (HMP) (HMP)

Age Related Macular Degeneration

Israel
Notal Vision Ltd.

Completed

Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients (UU2)

Age Related Macular Degeneration

Israel
Paloma Pharmaceuticals, Inc.

Completed

Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration (P52901)

Age-Related Macular Degeneration

United States
Russian Academy of Medical Sciences

Unknown

Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

Age-Related Macular Degeneration

Russian Federation
University of Malaya

Unknown

Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter

Age Related Macular Degeneration

Malaysia
Lawson Health Research Institute
St. Joseph's Healthcare Foundation

Completed

Determining the Effect of Antibiotic Drop Prophylaxis on the Conjunctival Flora

Age-Related Macular Degeneration

Canada
Oregon Health and Science University
Genentech, Inc.

Completed

Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Notal Vision Ltd.

Completed

Age-Related Macular Degeneration (AMD) - Usability Study (AMD)

Age Related Macular Degeneration
National Eye Institute (NEI)
QLT Inc.

Terminated

TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration (VERTACL)

Age-Related Macular Degeneration

United States
Royal Liverpool University Hospital

Unknown

Macular Function During Anti-VEGF Treatment (MAFAT)

Age Related Macular Degeneration

United Kingdom
University Health Network, Toronto

Completed

Detection of Topographic Residual Acuity in Patients With Age Related Macular Degeneration

Age-Related Macular Degeneration

Canada
National University of Singapore

Recruiting

Impact of Comprehensive Dietary Counseling on Dietary Quality, Mental Health, and Quality of Life in Older Adults

Aging | Age Problem | Age-related Cognitive Decline | Age-Related Atrophy

Singapore
University of Pittsburgh

Completed

Association Between Light Spectrum and Survival After Cataract Surgery

Glaucoma | Cataract | Age Related Macular Degeneration | Age-related Cataract | Circadian Rhythm Disorders

United States
Sequenom, Inc.

Completed

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Age-related Macular Degeneration | Choroidal Neovascular Age-related Macular Degeneration

United States
Lpath, Inc.

Unknown

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Neovascular Age Related Macular Degeneration

United States
VA Office of Research and Development

Recruiting

Active AMD Study to Improve Function in Veterans

Age Related Macular Degeneration (AMD)

United States
Oslo University Hospital

Not yet recruiting

Photobiomodulation for Dry Age Related Macula Degeneration

Age-Related Macular Degeneration | Photobiomodulation
Shin Kong Wu Ho-Su Memorial Hospital

Recruiting

Maximum Treatment Interval With Aflibercept T&E

Neovascular Age-related Macular Degeneration

Taiwan
Novartis Pharmaceuticals

Recruiting

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Neovascular Age-related Macular Degeneration

United Arab Emirates
Berner Augenklinik
medignition AG

Enrolling by invitation

Comparison of Rapid Aflibercept and Brolucizumab T&E in wAMD (SPARROW)

Wet Age-related Macular Degeneration

Switzerland
Shanghai Biomabs Pharmaceutical Co., Ltd.

Completed

Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration

China
Novartis Pharmaceuticals

Completed

Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE Study

Neovascular Age-related Macular Degeneration

Portugal
Michel Giunta
Bayer

Active, not recruiting

Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

Wet Age-related Macular Degeneration

Canada
Frank G. Holz
Radboud University Medical Center; Bayer; Hoffmann-La Roche; Novartis Pharmaceuticals and other collaborators

Active, not recruiting

Development of Novel Clinical Endpoints in Intermediate AMD (MACUSTAR)

Age Related Macular Degeneration (AMD)

Germany, Italy, Netherlands, United Kingdom, France, Portugal, Denmark
Qilu Pharmaceutical Co., Ltd.

Completed

A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD)

Wet Age-related Macular Degeneration

China
Novartis Pharmaceuticals

Completed

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (IRIS Study)

Age-related Macular Degeneration (AMD)

United States
Novartis Pharmaceuticals

Completed

Evaluation of Number of Patient Eyes That Remained on or Switched to Anti-VEGF Treatment After Initiation of Broluciumab

Age-related Macular Degeneration (AMD)

United States
Bioeq GmbH

Completed

Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascular Age-related Macular Degeneration (COLUMBUS-AMD)

Age-related Macular Degeneration (AMD)

France, Italy, Poland, Russian Federation, Spain, United Kingdom, Germany, Hungary, Ukraine, Austria, Czechia, Israel
i-Lumen Scientific, Inc.

Withdrawn

Microcurrent Stimulation for Dry Age-related Macular Degeneration (i-SIGHT)

Dry Age-related Macular Degeneration
Alkahest, Inc.

Completed

Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration

Wet Age-related Macular Degeneration

Hungary
Alcon, a Novartis Company

Completed

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

Exudative Age-Related Macular Degeneration

United States
Tennessee Retina
Regeneron Pharmaceuticals

Unknown

Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept (TRISTAR)

Neovascular Age-related Macular Degeneration

United States
Chinese Academy of Sciences
The First Affiliated Hospital of Zhengzhou University

Unknown

Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells

Dry Age-related Macular Degeneration

China
CHA University

Unknown

The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD

Dry Age Related Macular Degeneration

Korea, Republic of

Clinical Trials on Age, Parental

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations